Biggest Controversy @nishantshahmd - Bias & Inequity 🔹characteristics of sample population in training datasets unclear 🔹🚺, racial minorities, low SE status underrepresented 🔹potential to exacerbate health disparities

Biggest Challenge @nishantshahmd - Regulation Clinicians need to be actively participating in these discussions!

Biggest (Clinical) Concerns @nishantshahmd - Automation Bias & Liability 🔹Too much reliance on automated AI tools may make us stop thinking 🔹Who is liable when AI goes wrong? Developer vs hospital vs clinician 🔹Can not using AI make a clinician liable?

Excellent talk by @nishantshahmd emphasizing development of #AI tools to be held to the same scientific rigor as traditional research! @MyASNC #CVNuc #CardiacPET

Dr @MarthaGrogan1 highlights the role of #AI ECG in the earlier dx of ❤️ #Amyloidosis 🔹AL ~50% (+) 12m before dx 🔹ATTRwt most (+) up to 48m before Most patients get an ECG early in their dx journey - AI ECG can be + before clinical suspicion & typical imaging findings

Dr @MarthaGrogan1 points out how #AI ECG tool works great in the Amyloid clinic If the prevalence is 51%, PPV is 89% If the prevalence is 15%, PPV drops to 76% MODIFY AI model thresholds according to prevalence and pre-test probability

What are the benefits of AI in #CVImaging? @Yuki_Sahashi shares excellent examples - 🔹Do human tasks faster/more precisely - aortic stenosis, measurements, EF 🔹Do tasks humans cannot do - avg patient sees 4 cardiologist & 24-36 months before diagnosis of #Amyloidosis @MyASNC

Want to learn how #AI is impacting early diagnosis & prognosis in #CVImaging , #amyloidosis care and current/future #CVNuc practice? Join the experts @MyASNC at 5:30 pm today! @JBourqueMD @nishantshahmd @premsoman123 @David_Ouyang @MarthaGrogan1 Follow me for #SoMe updates!

Join me and a fantastic faculty tonight for an engaging discussion of the application of AI in cardiac amyloidosis and cardiovascular medicine. I hope to see you there!

Tomorrow, Dec 2 | 5:30–7 PM ET 💻LIVE Webinar: The AI Transformation in Nuclear Cardiology Learn how #AI is transforming cardiac #amyloidosis care, benefiting cardiovascular medicine, and the potential challenges ahead. ✨ Free for members Register➜ https://t.co/XAdGXT9Ks4

In which territory has SCAD occurred? Vote now. View the case next week in @MyASNC's Cardiac PET Resource Center:

New #CVNuc #ThinkPET case! 59-yr-old woman with ischemic CM due to SCAD is under consideration for revascularization. PET MPI performed to guide management. SCAD has occurred in which coronary territory? Vote below.

📢 Deadline Extended! Submit your abstracts & cases for #ICNC2026 by Nov 30—final deadline. 🌟Accepted abstracts will be published in the EANM Innovation Journal. 🌟Eligible submissions will be considered for awards & travel grants. Submit👉 https://t.co/AwUD4hNsFA

Deadline extended! 🎉 You still have until Sunday, November 30 to submit your abstract and case for #ICNC2026! Don't miss this chance to highlight your latest research and clinical cases to global leaders in #NuclearCardiology. Submit now 👉 https://t.co/MwkuvfGQKm

The abstract and case submission deadline for #ICNC2026 is approaching! 📍 Berlin, Germany 📅 May 17-19, 2026 🤝 Co-organised by EANM and @MyASNC Share your research and submit your abstract before November 25 👉 https://t.co/MwkuvfGiUO

📢 Early-Career Professionals: Submit your abstract for #ICNC2026 & be considered for the Avijit Lahiri Young Investigator Awards Competition. ✔️ Finalists get 🆓 registration 🏆 Awards: €1,000 / €750 / €500 🛫 Plus, travel grants up to €1,000 Submit👉 https://t.co/AwUD4hO0v8